ScoreWhy is Aurisco Pharmaceutical Co., Ltd. ?
1
Negative results in Sep 25
- INTEREST(HY) At CNY 17.36 MM has Grown at 210.44%
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.1 times
- DEBTORS TURNOVER RATIO(HY) Lowest at 4.24 times
2
With ROE of 16.35%, it has a fair valuation with a 3.73 Price to Book Value
- Over the past year, while the stock has generated a return of 25.25%, its profits have risen by 4.6% ; the PEG ratio of the company is 5
- At the current price, the company has a high dividend yield of 1.3
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Aurisco Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Aurisco Pharmaceutical Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Aurisco Pharmaceutical Co., Ltd.
20.26%
0.41
32.50%
China Shanghai Composite
15.17%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
20.69%
EBIT Growth (5y)
27.99%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.51
Tax Ratio
12.85%
Dividend Payout Ratio
32.54%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.19%
ROE (avg)
13.03%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
3.73
EV to EBIT
20.12
EV to EBITDA
16.51
EV to Capital Employed
3.70
EV to Sales
5.85
PEG Ratio
5.00
Dividend Yield
1.26%
ROCE (Latest)
18.39%
ROE (Latest)
16.35%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 389.64 MM
ROCE(HY)
Highest at 17.65%
RAW MATERIAL COST(Y)
Fallen by -7.78% (YoY
-11What is not working for the Company
INTEREST(HY)
At CNY 17.36 MM has Grown at 210.44%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.1 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.24 times
Here's what is working for Aurisco Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 389.64 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Raw Material Cost
Fallen by -7.78% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Aurisco Pharmaceutical Co., Ltd.
Interest
At CNY 17.36 MM has Grown at 210.44%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Inventory Turnover Ratio
Lowest at 1.1 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 4.24 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
